Disclosures for "Interim Results of the US Fenfluramine Oral Solution Cardiovascular Safety Registry Study"
-
Author has nothing to disclose
-
Dr. Morita has received personal compensation for serving as an employee of UCB Biosciences, Inc. Dr. Morita has stock in UCB, Inc.
-
Mrs. Shepherd-Smith has received personal compensation for serving as an employee of UCB Pharma S.A. Mrs. Shepherd-Smith has stock in UCB Pharma S.A.
-
Dr. Zhang-Roper has received personal compensation for serving as an employee of UCB.
-
Dr. Gitelson has received personal compensation for serving as an employee of UCB Biosciences Inc.. An immediate family member of Dr. Gitelson has received personal compensation for serving as an employee of Biogen Inc. Dr. Gitelson has stock in UCB Biosciences Inc.. An immediate family member of Dr. Gitelson has stock in Biogen Inc.
-
Miss Tselenti has nothing to disclose.
-
Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has stock in UCB.
-
Dr. Roberts has received personal compensation for serving as an employee of UCB Pharma. Dr. Roberts has stock in UCB Pharma.
-
Author has nothing to disclose